ACGN insider filings
Aceragen, Inc. — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-11. Screen ACGN transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ACGN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Aceragen, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-08-11 | 4 | GOWEN MAXINE — Director | Sale (S): 51 @ $0.51 | EDGAR |
| 2023-08-11 | 4 | MILANO VINCENT — Director | Sale (S): 3,283 @ $0.53 | EDGAR |
| 2023-07-19 | 4 | Pillar Invest Corp — 10% owner Pillar Partners Foundation, L.P. — 10% owner Pillar Pharmaceuticals 6, L.P. — 10% owner Umari Abude — 10% owner ZEIN YOUSSEF EL — 10% owner | Purchase (P): 26,965 @ $1.42 | EDGAR |
| 2023-07-19 | 4 | Pillar Invest Corp — 10% owner Pillar Partners Foundation, L.P. — 10% owner Pillar Pharmaceuticals 6, L.P. — 10% owner Umari Abude — 10% owner ZEIN YOUSSEF EL — 10% owner | Sale (S): 3,605 @ $1.58 · Sale (S): 2,213 @ $1.54 | EDGAR |
| 2023-05-18 | 4 | Chopra Atul — 10% owner | Sale (S): 6,887 @ $1.40 · Sale (S): 6,645 @ $1.41 · Sale (S): 8,469 @ $1.42 · Sale (S): 1,220 @ $1.43 · Sale (S): 3,369 @ $1.44 · Sale (S): 701 @ $1.45 · +19 more | EDGAR |
| 2023-05-18 | 4 | Chopra Atul — 10% owner | Sale (S): 23,890 @ $1.50 · Sale (S): 7,162 @ $1.51 · Sale (S): 4,676 @ $1.52 · Sale (S): 6,310 @ $1.53 · Sale (S): 3,199 @ $1.54 · Sale (S): 2,075 @ $1.55 · +15 more | EDGAR |
| 2023-05-18 | 4 | Chopra Atul — 10% owner | Sale (S): 3,734 @ $1.75 · Sale (S): 50 @ $1.76 · Sale (S): 81 @ $1.77 · Sale (S): 5,737 @ $1.78 · Sale (S): 4,151 @ $1.79 · Sale (S): 3,301 @ $1.80 · +14 more | EDGAR |
| 2023-02-02 | 4 | Taylor John Clayton — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 74,500 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Kraus Carl N — CHIEF MEDICAL OFFICER | Grant/award (A): 25,400 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Salain Daniel — CHIEF OPERATING OFFICER | Grant/award (A): 25,400 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Lim Bryant David — SVP AND GENERAL COUNSEL | Grant/award (A): 25,400 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | Kirby John J. — CHIEF FINANCIAL OFFICER | Grant/award (A): 25,400 (derivative) @ $0 | EDGAR |
| 2023-02-02 | 4 | JORDAN ANDREW R — CHIEF STRATEGY OFFICER | Grant/award (A): 25,400 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | Taylor John Clayton — Chief Executive Officer, Director | Option exercise (M): 1,341,764 · Option exercise (M): 22,810 (derivative) | EDGAR |
| 2023-01-19 | 4 | Kraus Carl N — Chief Medical Officer | Option exercise (M): 440,844 (derivative) | EDGAR |
| 2023-01-19 | 4 | Salain Daniel — Chief Operating Officer | Option exercise (M): 1,341,764 · Option exercise (M): 22,810 (derivative) | EDGAR |
| 2023-01-19 | 4 | WOOTEN RONALD J — Director | Conversion (C): 14,115 (derivative) · Conversion (C): 830,294 (derivative) | EDGAR |
| 2023-01-19 | 4 | JORDAN ANDREW R — Chief Strategy Officer | Option exercise (M): 402,529 · Option exercise (M): 6,843 (derivative) | EDGAR |
| 2023-01-18 | 4 | NovaQuest Co-Investment Fund XV, L.P. — Director NQ POF V GP, Ltd. — Director | Conversion (C): 14,115 (derivative) · Conversion (C): 830,294 (derivative) | EDGAR |
Recent 8-K events — Aceragen, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-08-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-07-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-07-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-30 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-04 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2023-03-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-02-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-17 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ACGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs